Superworth

Viatris market cap VTRS

Share price times shares outstanding: what the whole company sells for, since 2021.

Today, Nov 2, 2026
$21.4B
Highest close in our data
$21.9B
Oct 2026

Viatris is worth $21.4B at the close on Nov 2, 2026, at $18.67 a share.

That is up 84% over the last year and up 29% over five years.

Its highest close in our data was $21.9B in Oct 2026.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$21.4B$14.4B$21.9B+51%
2025$14.2B$9B$14.7B−5%
2024$14.9B$12.1B$16.2B+15%
2023$13B$10.5B$14.8B−4%
2022$13.5B$10.3B$18.4B−18%
2021$16.4B$14.8B$19.3Bn/a

Against its peers

Companies in Healthcare nearest Viatris' size, closest first, today.

CompanyMarket cap
VTRSViatris$21.4B
THCTenet Healthcare$21.5B
ALNYAlnylam Pharmaceuticals$21.2B
STESTERIS$22.7B
INCYIncyte$24.3B
ZBHZimmer Biomet$18.6B
MEDPMedpace$18.1B
UTHRUnited Therapeutics$25.9B
EXELExelixis$17.4B
RVTYRevvity$16.9B
DGXQuest Diagnostics$27.5B
Peer median$21.4B

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Viatris

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.